# Drug Use Investigation for HEPSERA (Adefovir) Tablet

> **NCT01863589** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 436 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Adefovir tablets

## Key facts

- **NCT ID:** NCT01863589
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2007-06
- **Final completion:** 2012-07
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2013-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01863589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01863589, "Drug Use Investigation for HEPSERA (Adefovir) Tablet". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01863589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*